Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001231919-26-000300 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 31, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
369,000
Total Value
$8,762,797.00
P&L
+28.1% (+$2,462,183.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 27, 2026 | Purchase | 310,700 | $23.67 | $7,354,269.00 | 5,767,221 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Mar 30, 2026 | Purchase | 58,300 | $24.16 | $1,408,528.00 | 5,825,521 | Indirect | See footnotes | View Details |